Last modified: August 9, 2022
Ph.D. Biochemistry, Banaras Hindu University
Professor of Pathology, University of Vermont Larner College of Medicine
UNVAS Award from the Indian Pharmacological Society
Society of American Asian Scientists in Cancer Research (SAASCR)
Editorial Board Member of American Journal of Respiratory Cell and Molecular Biology
External Advisory Committee, Perelman School of Medicine, University of Pennsylvania
About Arti Shukla, Ph.D.
Arti Shukla, Ph.D., has spent several decades researching the cell signaling mechanisms of asbestos fibers and how they lead to lung diseases, including lung cancer and mesothelioma. In 2021, the Society of American Asian Scientists in Cancer Research presented her with an Outstanding Achievement Award for seminal contributions to cancer research.
Shukla has earned several awards for her work and served as an asbestos consultant on national projects, including the Toxic Substances Control Act Science Advisory Committee on Chemicals.
She graduated from Banaras Hindu University with a Ph.D. in biochemistry in 1989 and completed post-doctorate research at the University of Michigan. Shukla currently serves as a research scientist at The University of Vermont.
Her most recent research in 2020 included breakthrough findings on extracellular vesicles in mesothelioma. These proteins can serve as potential biomarkers for early mesothelioma detection and may be a way to administer medicine to tumors safely.
Shukla is director of the Shukla Research Lab at The University of Vermont Larner College of Medicine and serves as a professor in the pathology department. Over the past 20 years, she has published nearly 100 studies on asbestos and asbestos diseases in globally acclaimed medical journals.
Her primary research endeavors include asbestos-induced signaling mechanisms in human mesothelial cells. One example is investigating how the ERK cell signaling pathway plays a role in developing malignant mesothelioma.
Shukla and her team at the Shukla Research Lab have also demonstrated the role of asbestos inflammation through mesothelioma particles called inflammasomes. Their goal is to reveal the role of inflammasomes in the development of mesothelioma and to manipulate them to develop potential new treatments.
The Shukla Research Lab is also exploring the role of exosomes in the development and therapy of mesothelioma. Their work will determine if exosomes carry information to mesothelial cells for the development of mesothelioma. They also hope to identify exosome signatures as biomarkers of asbestos exposure for early mesothelioma diagnosis.